Shanghai HeartCare Medical Technology Corporation Limited (HeartCare, HKEX: 06609) filed its monthly return for the period ended 31 July 2026, reporting no changes in authorised, issued or treasury shares.

The company’s authorised and registered share capital remained unchanged at 39.83 million shares with a par value of RMB 1 each. This total comprises 31.57 million H shares listed on the Stock Exchange of Hong Kong and 8.27 million unlisted ordinary shares.

Issued share capital also stayed flat. As at 31 July, HeartCare reported: • 30.59 million H shares in issue (excluding treasury shares), unchanged from the prior month. • 0.97 million H shares held in treasury, resulting in total issued H shares of 31.57 million. • 8.27 million unlisted shares outstanding, with no treasury position.

The company confirmed that it met the Main Board’s minimum public-float requirement of 25 % for its H share class.

No share options, warrants, convertible securities, or other equity-related arrangements were issued, exercised, or cancelled during the month. In addition, there were no movements involving Hong Kong Depositary Receipts.

The filing was authorised by Director Mr. Wang Guohui and submitted on 5 August 2026.